SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2025-10-28 15:37Core Viewpoint - The stock of Kaili Medical (300633) has shown mixed performance with a slight increase in price but significant outflows from major funds, indicating potential concerns among institutional investors [1][2]. Financial Performance - As of October 28, 2025, Kaili Medical's stock closed at 34.15 yuan, up 0.29% with a trading volume of 36,300 hands and a total transaction value of 124 million yuan [1]. - The company reported a main revenue of 1.459 billion yuan for the first three quarters of 2025, a year-on-year increase of 4.37%, but the net profit attributable to shareholders was 33.51 million yuan, down 69.25% year-on-year [3]. - The third quarter alone saw a main revenue of 495 million yuan, up 28.42% year-on-year, but a net loss of 13.52 million yuan, reflecting a 78.05% increase in losses compared to the previous year [3]. Fund Flow Analysis - On October 28, 2025, the net outflow of major funds was 13.95 million yuan, accounting for 11.25% of the total transaction value, while retail investors saw a net inflow of 15.39 million yuan, representing 12.41% of the total [1][2]. - Over the past five days, the trend shows consistent net outflows from major and speculative funds, with retail investors being the only group showing net inflows [2]. Industry Comparison - Kaili Medical's total market capitalization is 14.777 billion yuan, which is higher than the industry average of 11.668 billion yuan, ranking 21st out of 124 in the medical device industry [3]. - The company's net profit margin is significantly lower than the industry average, with a net profit margin of 2.3% compared to the industry average of 9.96%, ranking 89th out of 124 [3]. Analyst Ratings - In the last 90 days, 21 institutions have rated the stock, with 13 buy ratings and 8 hold ratings, indicating a generally positive outlook despite recent performance issues [4].